Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 NOK | +5.08% | +4.20% | -11.43% |
05-15 | BioFish Holding AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-22 | BioFish Holding AS Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 193.5 | 80.4 | 126.2 | 126.2 | - |
Enterprise Value (EV) 1 | 193.5 | 80.4 | 123.7 | 98.15 | 85.15 |
P/E ratio | - | - | -9.54 x | -20.7 x | 10.3 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 10.6 x | 3.97 x | 2.59 x | 1.8 x | 0.98 x |
EV / Revenue | 10.6 x | 3.97 x | 2.59 x | 1.4 x | 0.66 x |
EV / EBITDA | -28.6 x | - | -31.7 x | 8.92 x | 1.94 x |
EV / FCF | - | - | -2.79 x | -3.78 x | 6.55 x |
FCF Yield | - | - | -35.9% | -26.5% | 15.3% |
Price to Book | - | - | 0.54 x | 0.78 x | 0.69 x |
Nbr of stocks (in thousands) | 13,400 | 13,400 | 101,735 | 101,735 | - |
Reference price 2 | 14.44 | 6.000 | 1.240 | 1.240 | 1.240 |
Announcement Date | 5/31/22 | 5/30/23 | 3/22/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net sales 1 | 18.33 | 20.24 | 47.68 | 70 | 129 |
EBITDA 1 | -6.755 | - | -3.906 | 11 | 44 |
EBIT 1 | -7.155 | - | -10.16 | -1 | 32 |
Operating Margin | -39.04% | - | -21.3% | -1.43% | 24.81% |
Earnings before Tax (EBT) 1 | - | - | -12.32 | -6 | 29 |
Net income 1 | - | -14.89 | -12.01 | -7 | 22 |
Net margin | - | -73.56% | -25.19% | -10% | 17.05% |
EPS 2 | - | - | -0.1300 | -0.0600 | 0.1200 |
Free Cash Flow 1 | - | - | -61 | -26 | 13 |
FCF margin | - | - | -127.08% | -37.14% | 10.08% |
FCF Conversion (EBITDA) | - | - | - | - | 29.55% |
FCF Conversion (Net income) | - | - | - | - | 59.09% |
Dividend per Share | - | - | - | - | - |
Announcement Date | 5/31/22 | 5/30/23 | 3/22/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 S1 | 2022 Q1 | 2022 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 7.681 | 1.98 | 1.98 | 27.58 | - | 17.19 | 3.2 | 27 | 27 |
EBITDA 1 | - | -6.32 | -6.32 | - | -8.517 | -0.831 | -5 | 7 | 7 |
EBIT 1 | - | -6.92 | -6.92 | - | -11.52 | -2.282 | -8 | 4 | 4 |
Operating Margin | - | -349.49% | -349.49% | - | - | -13.28% | -250% | 14.81% | 14.81% |
Earnings before Tax (EBT) 1 | - | -7.03 | - | - | -13.11 | -3.831 | -9 | 3 | 3 |
Net income 1 | - | -7.03 | - | 8.083 | -12.8 | -3.831 | -9 | 2 | 2 |
Net margin | - | -355.05% | - | 29.31% | - | -22.29% | -281.25% | 7.41% | 7.41% |
EPS 2 | - | - | - | - | - | - | -0.0900 | 0.0100 | 0.0100 |
Dividend per Share | - | - | - | - | - | - | - | - | - |
Announcement Date | 9/30/21 | 9/30/22 | 9/30/22 | 12/14/23 | 3/22/24 | 5/15/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Debt 1 | - | - | 44 | - | - |
Net Cash position 1 | - | - | - | 28 | 41 |
Leverage (Debt/EBITDA) | - | - | -22 x | - | - |
Free Cash Flow 1 | - | - | -61 | -26 | 13 |
ROE (net income / shareholders' equity) | - | - | - | - | 9.5% |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share 2 | - | - | 2.300 | 1.600 | 1.800 |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | - | - | 43 | 12 | 12 |
Capex / Sales | - | - | 89.58% | 17.14% | 9.3% |
Announcement Date | 5/31/22 | 5/30/23 | 3/22/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.43% | 11.93M | |
+13.35% | 3.38B | |
0.00% | 1.09B | |
+6.81% | 774M | |
-.--% | 500M | |
+32.16% | 424M | |
-16.81% | 399M | |
+25.00% | 377M | |
-11.99% | 361M | |
+14.61% | 355M |
- Stock Market
- Equities
- BFISH Stock
- Financials BioFish Holding